NextCure, Inc. - Common Stock (NXTC)
Historical Holders from Q2 2019 to Q3 2025
-
Type / Class
-
Equity / Common Stock
-
Symbol
-
NXTC on Nasdaq
-
Shares outstanding
-
28,027,744
-
Price per share
-
$5.86
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares as of 30 Sep 2025
-
21,833
-
Holdings value
-
$127,941
-
% of all portfolios
-
0%
-
Share change
-
-10,523,357
-
Value change
-
-$6,933,766
-
Average sells %
-
-0%
-
Number of holders
-
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of NextCure, Inc. - Common Stock (NXTC) based on Schedule 13D/G filings
| Filer |
Ownership |
Change % |
Holdings Value |
Net Change |
Nb Shares |
Change % |
Reporting Name |
Report Period |
|
CITIGROUP INC
|
4.3%
|
|
$506,181
|
|
1,205,193
|
|
Citigroup Global Markets Inc.
|
31 Mar 2025
|
As of 30 Sep 2025, NextCure, Inc. - Common Stock (NXTC) has 1 institutional shareholder filing 13F forms.
They hold 21,833 shares
of 28,027,744 outstanding shares (0.08%)
.
Institutional Holders of NextCure, Inc. - Common Stock (NXTC) across Reporting Periods
| Period |
Reported Shares, Excl. Options |
Value, Excl. Options |
Value Change |
Puts Notional Value |
Calls Notional Value |
Price |
Investors |
|
2025 Q3
|
21,833 |
$127,941 |
-$6,933,766 |
|
|
$5.86 |
1 |
|
2025 Q2
|
10,545,575 |
$5,647,089 |
-$11,042,788 |
|
$0 |
$0.4600 |
29 |
|
2025 Q1
|
15,365,612 |
$7,377,835 |
-$659,368 |
|
$817 |
$0.4803 |
38 |
|
2024 Q4
|
14,576,884 |
$11,238,169 |
-$3,082,628 |
|
|
$0.7710 |
45 |
|
2024 Q3
|
15,865,008 |
$21,732,882 |
-$163,706 |
|
$0 |
$1.37 |
44 |
|
2024 Q2
|
16,009,076 |
$25,452,390 |
-$417,831 |
|
$2,226 |
$1.59 |
47 |
|
2024 Q1
|
16,144,047 |
$35,999,098 |
+$6,299,292 |
|
$23,415 |
$2.23 |
46 |
|
2023 Q4
|
13,341,936 |
$15,275,154 |
-$369,923 |
|
$228 |
$1.14 |
42 |
|
2023 Q3
|
12,895,574 |
$16,633,500 |
-$700,863 |
|
$36,636 |
$1.29 |
39 |
|
2023 Q2
|
13,318,875 |
$23,971,765 |
+$169,807 |
|
$87,480 |
$1.80 |
42 |
|
2023 Q1
|
13,265,273 |
$19,631,094 |
-$159,489 |
|
$92,352 |
$1.48 |
42 |
|
2022 Q4
|
13,389,531 |
$18,876,133 |
-$5,000,007 |
$0 |
$86,574 |
$1.41 |
44 |
|
2022 Q3
|
15,242,782 |
$41,759,784 |
+$1,686,368 |
$226,000 |
$65,000 |
$2.75 |
48 |
|
2022 Q2
|
14,456,827 |
$67,938,572 |
+$5,637,581 |
$369,000 |
$1,087,000 |
$4.70 |
49 |
|
2022 Q1
|
13,233,257 |
$64,321,105 |
-$6,638,844 |
$258,000 |
$217,000 |
$4.86 |
57 |
|
2021 Q4
|
14,366,664 |
$86,200,310 |
-$4,439,158 |
$255,000 |
$494,000 |
$6.00 |
68 |
|
2021 Q3
|
14,744,107 |
$99,459,595 |
-$5,380,167 |
$290,000 |
$537,000 |
$6.74 |
66 |
|
2021 Q2
|
15,461,583 |
$124,156,911 |
-$24,114,984 |
$972,000 |
$1,626,000 |
$8.03 |
74 |
|
2021 Q1
|
17,959,308 |
$179,779,328 |
+$33,903,656 |
$2,948,000 |
$1,035,000 |
$10.01 |
91 |
|
2020 Q4
|
14,545,518 |
$158,547,717 |
-$35,131,387 |
$1,366,000 |
$1,756,000 |
$10.90 |
80 |
|
2020 Q3
|
18,265,185 |
$160,694,375 |
-$76,990,689 |
$626,000 |
$1,229,000 |
$8.80 |
73 |
|
2020 Q2
|
20,244,521 |
$434,046,210 |
-$4,189,870 |
$959,000 |
$322,000 |
$21.44 |
87 |
|
2020 Q1
|
20,204,298 |
$748,968,161 |
-$2,574,956 |
$2,176,000 |
$0 |
$37.07 |
81 |
|
2019 Q4
|
20,192,753 |
$1,137,417,349 |
+$381,121,391 |
$1,138,000 |
$439,000 |
$56.33 |
88 |
|
2019 Q3
|
11,288,924 |
$348,260,350 |
+$50,213,398 |
|
|
$30.85 |
52 |
|
2019 Q2
|
10,754,678 |
$161,093,210 |
+$161,093,000 |
|
|
$14.98 |
42 |